Schutte, R;
Whincup, PH;
Papacosta, O;
Lennon, LT;
Macfarlane, PW;
Wannamethee, G;
(2017)
Liver enzymes are not directly involved in atrial fibrillation: a prospective cohort study.
European Journal of Clinical Investigation
, 47
(8)
pp. 583-590.
10.1111/eci.12779.
Preview |
Text
Lennon_AF and GGT_R1.pdf - Accepted Version Download (362kB) | Preview |
Preview |
Text
Lennon_Supplementary File.pdf - Accepted Version Download (222kB) | Preview |
Abstract
BACKGROUND: Epidemiological evidence proposes the direct involvement of the liver enzymes in atrial fibrillation. These relationships are controversial and mechanistically unclear. As part of the British Regional Heart Study, we investigated whether change in liver enzymes over time associates with atrial fibrillation in men initially free of this heart condition. MATERIALS AND METHODS: We prospectively investigated change (delta) in liver enzymes and new-onset atrial fibrillation in a representative sample of 1428 men aged 60–79 years. RESULTS: Mean follow-up was 12·3 years, after which 108 new atrial fibrillation cases were identified. The liver enzymes did not differ at baseline or follow-up, except for gamma-glutamyl transferase which was higher at follow-up in men who developed atrial fibrillation compared to those who did not (P < 0·0001). Change in GGT was greater in men who developed AF than those who did not (+6·12 vs. −2·60 U/L, P = 0·036). N-terminal pro-brain natriuretic peptide (baseline and follow-up, P < 0·0001) and total bilirubin (follow-up only, P < 0·0001) were also higher in men who developed atrial fibrillation while serum haemoglobin was similar at baseline and follow-up (P ≥ 0·74). Atrial fibrillation was associated with change in gamma-glutamyl transferase (OR, 1·18; 95% CI, 1·01–1·37) after multiple adjustments and exclusions. However, after adjusting for baseline (P = 0·088) or change (P = 0·40) in N-terminal pro-brain natriuretic peptide, the association between atrial fibrillation and change in gamma-glutamyl transferase was lost. CONCLUSION: The direct relationship between atrial fibrillation and liver enzymes is absent and depends, at least in part, on the progression of heart failure as captured by N-terminal pro-brain natriuretic peptide.
Type: | Article |
---|---|
Title: | Liver enzymes are not directly involved in atrial fibrillation: a prospective cohort study |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1111/eci.12779 |
Publisher version: | http://doi.org/10.1111/eci.12779 |
Language: | English |
Additional information: | © 2017 Stichting European Society for Clinical Investigation Journal Foundation. This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
Keywords: | Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, Medicine, Research & Experimental, General & Internal Medicine, Research & Experimental Medicine, Atrial fibrillation, heart failure, liver enzymes, GAMMA-GLUTAMYL-TRANSFERASE, HEART-FAILURE, CARDIOVASCULAR-DISEASE, GENERAL-POPULATION, SERUM, RISK, GLUTAMYLTRANSFERASE, METAANALYSIS, DYSFUNCTION, PREVALENCE |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health > Primary Care and Population Health |
URI: | https://discovery.ucl.ac.uk/id/eprint/10023436 |
Archive Staff Only
![]() |
View Item |